| Structure |
Chemical Name |
CAS |
MF |
 |
Gabapentin Related Compound D |
1076198-17-8 |
C18H29NO3 |
 |
Desfluoro Risperidone |
106266-09-5 |
C23H28N4O2 |
![4-[Methyl[(2-amino-4-hydroxypteridine)-6-ylmethyl]amino]benzoic acid](/CAS/GIF/5623-18-7.gif) |
4-[Methyl[(2-amino-4-hydroxypteridine)-6-ylmethyl]amino]benzoic acid |
5623-18-7 |
C15H14N6O3 |
 |
6,6'-DiMethoxy-2,2'-binaphthalene |
29619-45-2 |
C22H18O2 |
 |
Cetirizine Ethyl Ester (USP RC A) |
246870-46-2 |
C23H29ClN2O3 |
 |
Duloxetine IMpurity A |
947686-09-1 |
C25H23NO3S |
 |
Labetalol IMpurity A |
1391051-99-2 |
C19H23NO4 |
 |
Citalopram Related Compound E |
|
|
![octahydro-2-nitrosocyclopenta[c]pyrrole](/CAS/GIF/54786-86-6.gif) |
octahydro-2-nitrosocyclopenta[c]pyrrole |
54786-86-6 |
C7H12N2O |
 |
Clazuril |
101831-36-1 |
C17H10Cl2N4O2 |
 |
LEVOCARNITINE RELATED COMPOUND A (100 MG) (3-CARBOXY-N,N,N-TRIMETHYL-2-PROPEN-1-AMINIUM CHLORIDE) |
6538-82-5 |
C7H13ClNO2 |
 |
Levomepromazine hydrochloride |
1236-99-3 |
C19H24N2OS.ClH |
 |
LevetiracetaM IMpurity B |
358629-47-7 |
C8H12N2O2 |
 |
1-Cyano-3-isopropylguanidine |
44830-55-9 |
C5H10N4 |
![Tioconazole Related Compound A (25 mg) (1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride)](/CAS/20180808/GIF/61709-33-9.gif) |
Tioconazole Related Compound A (25 mg) (1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride) |
61709-33-9 |
C16H15Cl3N2OS |
 |
Loratadine EP IMpurity F |
125743-80-8 |
C22H24ClFN2O2 |
 |
SulfaMethoxazole N4-glucoside |
119691-75-7 |
C16H21N3O8S |
 |
4-Nitro-2-phenoxyaniline |
5422-92-4 |
C12H10N2O3 |
 |
GLIMEPIRIDE RELATED COMPOUND C (20 MG) (GLIMEPIRIDE URETHANE) |
119018-30-3 |
C18H23N3O6S |
 |
INSULIN LISPRO (5.97 MG) |
133107-64-9 |
C257H383N65O77S6 |
 |
TRAMADOL IMPURITY E |
|
C16H25NO2 |
 |
FLUCONAZOLE IMPURITY B |
|
C13H12F2N6O |
 |
ChlorproMazine Sulfoxide |
969-99-3 |
C17H19ClN2OS |
|
|
Fosinopril Related Compound B |
|
|
 |
Trimethoprim Related Compound B (25 mg) (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone) (AS) |
30806-86-1 |
C14H16N4O4 |
 |
4'-(pyrimidin-2-ylsulphamoyl)acetanilide |
127-74-2 |
C12H12N4O3S |
 |
Fosinopril Related Compound D |
1356353-41-7 |
C30H47NNaO7P |
 |
1H-Imidazol-5-amine,1-methyl-4-nitro-(9CI) |
4531-54-8 |
C4H6N4O2 |
 |
Proguanil Related Compound C (25 mg) (1,5-bis(4-chlorophenyl)biguanide hydrochloride) |
13590-98-2 |
C14H14Cl3N5 |
![[2S-[1[R*(R*)],2α,3aβ,6aβ]]-1-[2-[[3-Cyclohexyl-1-(ethoxycarbonyl)propyl]aMino]-1-oxoprop](/CAS/20150408/GIF/99742-35-5.gif) |
[2S-[1[R*(R*)],2α,3aβ,6aβ]]-1-[2-[[3-Cyclohexyl-1-(ethoxycarbonyl)propyl]aMino]-1-oxoprop |
99742-35-5 |
C23H38N2O5 |
![1-[(2S)-3-BroMo-2-Methyl-1-oxopropyl]-L-proline](/CAS/GIF/80629-35-2.gif) |
1-[(2S)-3-BroMo-2-Methyl-1-oxopropyl]-L-proline |
80629-35-2 |
C9H14BrNO3 |
 |
N-Des(cyclohexylaMinocarbonyl) Glipizide |
1346600-54-1 |
C14H16N4O3S |
 |
Ticabesone Propionate |
73205-13-7 |
C25H32F2O5S |
|
|
OXALIPLATIN IMPURITY B |
|
|
 |
PYRANTEL IMPURITY A |
36700-38-6 |
C11H14N2S |
 |
estra-1,3,5(10)-triene-3,17beta-diol 17-butyrate |
18069-79-9 |
C22H30O3 |
 |
N-Succinyl-L-tyrosine |
374816-32-7 |
C13H15NO6 |
 |
rac N-Desisopropyl-N-ethyl Acebutolol |
441019-91-6 |
C17H26N2O4 |
 |
Citalopram Related Compound H (25 mg) (1-(4'-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide) |
479065-02-6 |
C19H22Br2FNO |
![(2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one](/CAS/20180808/GIF/88308-22-9.gif) |
(2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one |
88308-22-9 |
C21H25NO3 |
![2-[(1,1-DIMETHYLETHYL) AMINO]-1-[4-OH-3-(HYDROXYMETHYL)PHENYL]ETHAN-1-ONE](/CAS/GIF/156547-62-5.gif) |
2-[(1,1-DIMETHYLETHYL) AMINO]-1-[4-OH-3-(HYDROXYMETHYL)PHENYL]ETHAN-1-ONE |
156547-62-5 |
C13H19NO3 |
|
|
INSULIN ASPART |
116094-23-6 |
C256H381N65O79S6 |
![METHYL 6-CHLORO-1H-BENZO[D]IMIDAZOL-2-YLCARBAMATE](/CAS/GIF/20367-38-8.gif) |
METHYL 6-CHLORO-1H-BENZO[D]IMIDAZOL-2-YLCARBAMATE |
20367-38-8 |
C9H8ClN3O2 |
![1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino] hydrochloride](/CAS/GIF/16899-81-3.gif) |
1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino] hydrochloride |
16899-81-3 |
C11H15NO3.ClH |
 |
Talampicillin hydrochloride |
39878-70-1 |
C24H23N3O6S.ClH |
 |
Citalopram Related Compound B |
1332724-03-4 |
C22H23FN2O6 |
|
|
Fosinopril Related Compound C |
|
|
![[3-[2-(diMethylaMino)ethyl]-2-[[3-[2-(diMethylaMino)ethyl]-1H-indol-5-yl]Methyl]-1H-indol-5-yl]-N-MethylMethanesulfonaMide, succinate salt](/CAS/GIF/545338-89-4.gif) |
[3-[2-(diMethylaMino)ethyl]-2-[[3-[2-(diMethylaMino)ethyl]-1H-indol-5-yl]Methyl]-1H-indol-5-yl]-N-MethylMethanesulfonaMide, succinate salt |
545338-89-4 |
C27H37N5O2S |
 |
Meta-Fexofenadine |
479035-75-1 |
C32H39NO4 |
 |
TINIDAZOLE RELATED COMPOUND B (20 MG) (1-(2-ETHYL-SULFONYLETHYL)-2-METHYL-4-NITROIMIDAZOLE) |
25459-12-5 |
C8H13N3O4S |
|
|
BUPIVACAINE IMPURITY B |
|
|
 |
Platinum, (1,2-cyclohexanediamine-N,N')dinitrato-,(sp-4-2, 1R-trans)- |
66900-68-3 |
C6H12N4O6Pt |
 |
Proguanil Related Compound D (25 mg) (1,5-bis(1-methylethyl)biguanide hydrochloride) |
35708-82-8 |
C8H20ClN5 |
 |
Propoxyphene Related Compound B (50 mg) (alpha-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane) |
53990-51-5 |
C21H27NO2 |
![4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE-3-CARBOXYLIC ACID, 8-FLUORO-5,6-DIHYDRO-5-METHYL-6-OXO-](/CAS/GIF/84378-44-9.gif) |
4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE-3-CARBOXYLIC ACID, 8-FLUORO-5,6-DIHYDRO-5-METHYL-6-OXO- |
84378-44-9 |
C13H10FN3O3 |
 |
DIAZEPAM RELATED COMPOUND B (25 MG) (3-AMINO-6-CHLORO-1-METHYL-4-PHENYLCARBOSTYRIL) |
5220-02-0 |
C16H13ClN2O |
 |
10-Formylfolic Acid |
134-05-4 |
C20H19N7O7 |
 |
Dextranomer |
56087-11-7 |
C41H68O30X4 |
|
|
Fosinopril Related Compound E |
|
|
 |
Lisinopril Cyclohexyl Analog |
1132650-67-9 |
C21H37N3O5 |
 |
Trospium Chloride Related Compound C |
3464-71-9 |
C16H15ClO2 |
 |
cis-Atovaquone |
137732-39-9 |
C22H19ClO3 |
|
|
MAIZE POWDER MA 1.0 IRMM CERTIFIED RE-F |
68525-86-0 |
|
![KETAMINE RELATED COMPOUND A (50 MG) (1 -[(2-CHLOROPHENYL)(METHYLIMINO)METHYL]CYLCOPENTA-NOL)](/CAS/GIF/6740-87-0.gif) |
KETAMINE RELATED COMPOUND A (50 MG) (1 -[(2-CHLOROPHENYL)(METHYLIMINO)METHYL]CYLCOPENTA-NOL) |
6740-87-0 |
C13H16ClNO |
![2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-](/CAS/GIF/41411-66-9.gif) |
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]- |
41411-66-9 |
C22H25ClN2O8 |
 |
GLUCOSAMINE SULFATE SODIUM CHLORIDE |
1296149-13-7 |
C6H15ClNNaO9S |
 |
Δ2-Cefuroxime Axetil |
123458-61-7 |
C20H22N4O10S |
 |
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) |
35888-94-9 |
C19H16O4 |
 |
Dalasetron (Mesylate hydrate) |
878143-33-0 |
C20H24N2O6S |
 |
TICLOPIDINE IMPURITY F |
62019-75-4 |
C14H14ClNS |
![(endo,anti)-(±)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide](/CAS/20210111/GIF/58073-59-9.gif) |
(endo,anti)-(±)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide |
58073-59-9 |
C20H30BrNO3 |
![(±)-N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide](/CAS/GIF/22568-64-5.gif) |
(±)-N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide |
22568-64-5 |
C16H24N2O4 |
 |
alpha-Methyl-4-biphenylacetic acid |
6341-72-6 |
C15H14O2 |
 |
Zinc acexamate |
70020-71-2 |
C16H28N2O6Zn |
 |
(R)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE |
103765-01-1 |
C8H14N2O2 |
 |
Olopatadine N-Oxide |
203188-31-2 |
C21H23NO4 |
 |
INDINAVIR (100 MG)F0D3080.971MG/MG(AI) |
180683-37-8 |
C36H49N5O5 |
|
|
BUPIVACAINE IMPURITY E |
|
|
|
|
FENTICONAZOLE IMPURITY D |
|
|
|
|
HYOSCINE BUTYLBROMIDE IMPURITY E |
|
|
 |
CEFACLOR, DELTA-3-ISOMER (30 MG) |
152575-13-8 |
C15H14ClN3O4S |
 |
(9Z,12Z)-octadeca-9,12-dienoic acid, monoester with glycerol |
26545-74-4 |
C21H38O4 |
![D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis-](/CAS/GIF/105816-06-6.gif) |
D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis- |
105816-06-6 |
C19H27NO3 |
 |
N-isopropyltropinium |
58005-18-8 |
C11H22BrNO |
![(2S)-1-[2-Methylpropanoyl]-pyrrolidine-2-carboxylic Acid](/CAS/20130318/GIF/CB92605022.gif) |
(2S)-1-[2-Methylpropanoyl]-pyrrolidine-2-carboxylic Acid |
23500-15-4 |
C9H15NO3 |
 |
1-Methyl-2-(Methylthio)iMidazole |
14486-52-3 |
C5H8N2S |
|
|
Abacavir Related CoMpound B |
|
|
|
|
GalantaMine HydrobroMide Related CoMpounds Mixture |
|
|
 |
Ranitidine Resolution Mixture |
|
C13H22N4O3S |
 |
Flutrimazole carbinol |
128092-72-8 |
C19H14F2O |
|
|
WARFARIN RELATED COMPOUND A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) |
37209-23-7 |
|
 |
ERYTHROMYCIN B |
527-75-3 |
C37H67NO12 |
|
|
ENDOTOXIN STANDARD |
|
|
|
|
HYDROUS BENZOYL PEROXIDE - REFERENCE SPECTRUM |
|
|
|
|
HEPARIN LOW-MOLECULAR-MASS FOR CALIBRATION CRS |
|
|
|
|
OXYTOCIN/DESMOPRESSIN VALIDATION MIXTURE |
|
|
|
|
POTASSIUM CLAVULANATE - REFERENCE SPECTRUM |
|
|
|
|
OXALIPLATIN IMPURITY D |
|
|
 |
ESTRADIOL FOR PEAK IDENTIFICATION |
|
C18H24O2 |
 |
6alpha-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-pivalate |
29205-06-9 |
C27H37FO5 |